HomeGRWRHITECH › Filing
🔔 Get instant alerts when GRWRHITECH files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 06 Aug 2026, 13:04 IST Exchange: NSE Category: Financial Results — Investor Presentation
AI summary - Q1FY27 revenue grew 28% YoY; PAT increased 60% YoY - Strong demand across key product categories supported growth - New Sun Control Film line capacity expansion underway - Value-added specialty films contribute 87% of revenue with 17% CAGR FY21-FY26 - Export share at 75%, with presence in 90+ countries - EBITDA margin improved to 30.3% in Q1FY27 - Cash surplus of Rs 774 Cr and net zero debt - Planned TPU line capex Rs 118 Cr in Q3 FY27 with 360 LSF capacity - FY27 & beyond: revenue CAGR target 15-20%, EBITDA margin 23-27% - ESG initiatives include GreenPro certification and advanced waste management
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 GRWRHITECH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add GRWRHITECH to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Garware Hi-Tech Films Limited

Important. The summary above is generated automatically from Garware Hi-Tech Films Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.